STEPHEN M. KANOVSKY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

NEOGENOMICS INC

Filing Date Source Excerpt
2018-04-20 Stephen M. Kanovsky, age 55. Mr. Kanovsky has served as a director since July 2017. ... As Directors pursuant to the Investor Board Rights Lockup and Standstill Agreement between NeoGenomics and GE, both Mr. Murphy and Mr. Kanorsky have declined to accept fees, stock awards and warrant/option awards.
2019-04-22 Stephen M. Kanovsky, age 56. Mr. Kanovsky has served as a director since July 2017. He is Chairman of the Nominating and Corporate Governance Committee. Director compensation table notes that he declined compensation in 2018.
2020-04-15 Stephen M. Kanovsky, age 57. Mr. Kanovsky has served as a director since July 2017. Mr. Kanovsky, who has worked at General Electric since 2012, is General Counsel, Commercial of GE Healthcare, a business unit of General Electric that provides medical technologies and solutions to the global healthcare industry.
2021-04-15 Stephen M. Kanovsky, age 58. Mr. Kanovsky has served as a director since July 2017. Mr. Kanovsky is General Counsel, Commercial of GE Healthcare.
2022-04-14 Stephen M. Kanovsky, age 59, Board Member and Chair of the Nominating and Corporate Governance Committee. Mr. Kanovsky has served as a director since July 2017. ... Stephen M. Kanovsky 63,125 Fees Earned or Paid in Cash, 126,000 Stock Awards, 54,000 Option Awards, Total 243,125.
2025-04-08 Stephen M. Kanovsky - Mr. Kanovsky has served as a director since July 2017. He is Chair of the Nominating and Corporate Governance Committee and serves on the Audit and Finance Committee and Compliance Committee. For service as a director during 2024, Mr. Kanovsky received total compensation of $312,050.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-19